Status:
NOT_YET_RECRUITING
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
HIV
Stimulant Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency m...
Detailed Description
Stimulant use (cocaine/ methamphetamine) has a major impact on HIV transmission and acquisition. Justice-involved individuals are more likely to have stimulant use disorders and be at risk or living w...
Eligibility Criteria
Inclusion
- Be 18 years of age or older
- Have a DSM-5 diagnosis of stimulant use disorder (methamphetamine and/or cocaine)
- Be at risk for or living with HIV
- Be transitioning to the community from a closed justice setting, such as:
- Jail Prison Justice-mandated residential substance use program
- Be able to provide informed consent
- Be willing and able to use a smartphone app (DynamiCare)
Exclusion
- Severe medical or psychiatric disability making participation unsafe
- Unable to provide consent or engage with the intervention
Key Trial Info
Start Date :
January 5 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 5 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07136363
Start Date
January 5 2026
End Date
January 5 2027
Last Update
November 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520
2
Parkland County Hospital
Dallas, Texas, United States, 75235